Abstract:Importance: New-onset diabetes after the age of 50 years is a potential indicator of pancreatic cancer. Understanding the associations between hyperglycemia, diabetes, and pancreatic cancer, including pancreatic ductal adenocarcinoma, is key to developing an approach to early detection.Objective: To assess the association of elevation in glycated hemoglobin (HbA1c) with the risk of pancreatic cancer.Design, Setting, and Participants: This cohort study was conducted using data collected from an integrated health care system in California. A total of 851 402 patients aged 50 to 84 years who had HbA1c measurements taken between 2010 and 2014 were identified as the base cohort, with 12 contemporaneous cohorts created based on varying HbA1c thresholds (ie, 6.1%, 6.3%, 6.5%, and 6.7%) and prior diabetes status. Data analysis was conducted from August 2018 to September 2019.Main Outcomes and Measures: New cases of pancreatic cancer identified through cancer registry and California death files during a 3-year period. Three-year risk, incidence rate, sensitivity, number of patients needed to screen to detect 1 case, timing, and stage at diagnosis were determined.Results: Among 851 402 patients in the base cohort, 447 502 (52.5%) were women, 255 441 (30.0%) were Hispanic participants, 383 685 (45.1%) were non-Hispanic white participants, 100 477 (11.8%) were Asian participants, and 88 969 (10.4%) were non-Hispanic black participants, with a median (interquartile range) age of 62 (56-69) years and a median (interquartile range) HbA1c level of 6.0% (5.7%-6.6%). The incidence rate of pancreatic cancer was 0.45 (95% CI, 0.43-0.49) per 1000 person-years. After excluding prior diabetes as well as confirmation of new-onset hyperglycemia based on an HbA1c level of 6.5%, a total of 20 012 patients remained, with 74 of 1041 pancreatic ductal adenocarcinoma cases (7.1%) from the base cohort included. The rate of pancreatic cancer was 0.72 (95% CI, 0.32-1.42) per 1000 person-years among Asian patients, 0.83 (95% CI, 0.35-1.71) per 1000 person-years among non-Hispanic black patients, 0.84 (95% CI, 0.48-1.37) per 1000 person-years among Hispanic patients, and 2.37 (95% CI, 1.75-3.14) per 1000 person-years among non-Hispanic white patients. Overall, 42 of 74 cancers (56.8%) were diagnosed within 1 year of the index laboratory test. Among 1041 total cases, 708 (68.0%) had staging information available, of whom 465 (65.7%) had stage III or IV disease at diagnosis. In the base cohort, the number needed to undergo evaluation to identify a single case of pancreatic ductal adenocarcinoma was 818 (95% CI, 770-869), with estimates ranging from 206 (95% CI, 160-264) to 600 (95% CI, 540-666) in the subcohorts.Conclusions and Relevance: The findings of this study suggest that screening patients for pancreatic cancer based solely on elevation in HbA1c level is unlikely to represent an effective strategy. Future efforts to identify a high-risk population based on changes in glycemic parameters should account for racial/ethnic differences.

Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis

Blood glucose concentration and risk of liver cancer: systematic review and meta-analysis of prospective studies

A Linear Dose-Response Relationship between Fasting Plasma Glucose and Colorectal Cancer Risk: Systematic Review and Meta-analysis

Prediabetes increases the risk of pancreatic cancer: A meta-analysis of longitudinal observational studies

Pancreatic Cancer Risk in Prediabetes: A Systematic Meta-Analysis Approach

Diabetes, Plasma Glucose And Incidence Of Pancreatic Cancer: A Prospective Study Of 0.5 Million Chinese Adults And A Meta-Analysis Of 22 Cohort Studies

Prediabetes And The Risk Of Pancreatic Cancer: A Meta-Analysis

Prediabetes and the risk of cancer: a meta-analysis

Effect of glycemic control on the risk of pancreatic cancer: A nationwide cohort study

Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case-Control Study

Association between prediabetes and the incidence of gastric cancer: A meta-analysis

Type 2 diabetes prevention diet and the risk of pancreatic cancer: A large prospective multicenter study

Association of Glycated Hemoglobin Levels With Risk of Pancreatic Cancer

Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: results from a longitudinal cohort and mendelian randomization study

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies.

[Study on the Relationship Between Level of Glucose Metabolism and Risk of Cancer Incidents].

Research on the Relationships Between Pancreatic Cancer and Hyperglycemia in Chinese Populations

Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium

Metformin is Associated with Reduced Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Hypoglycemic Agents and Incidence of Pancreatic Cancer in Diabetic Patients: a Meta-Analysis

Diabetes, prediabetes and cancer mortality